Call for Abstract

6th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs, will be organized around the theme “Enhance competency in HIV Prevention and Care”

STD-HIV AIDS 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in STD-HIV AIDS 2018

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

HIV stands for Human immunodeficiency virus. It harms your immune system by destroying the white blood cells that fight infection. This puts you at risk for serious infections and certain cancers. AIDS stands for Acquired Immuno Deficiency Syndrome. It is the final stage of infection with HIV. Not everyone with HIV develops AIDS. People affected by this virus will be susceptible to opportunistic infection or susceptible to tumors. AIDS is the most severe phase of HIV infection.

  • Track 1-1Pathogens of HIV Infection
  • Track 1-2Acute HIV infection
  • Track 1-3Clinical latency (HIV inactivity or dormancy)
  • Track 1-4Acquired immunodeficiency syndrome (AIDS)
  • Track 1-5Awareness and knowledge on HIV/AIDS, STDs and STIs
  • Track 1-6Diagnosis and Tests
  • Track 1-7HIV Prevention
  • Track 1-8HIV Testing

The best way to prevent HIV and other sexually transmitted infections (STIs) is to use a condom for penetrative sex and a dental dam for oral sex. The best way to prevent HIV is to use a condom for sex and to never share needles or other injecting equipment (including syringes, spoons and swabs).

To help prevent the spread of HIV

  • Take antiretroviral medicines. Getting treated for HIV can help prevent the spread of HIV to people who are not infected.
  • Tell your sex partner or partners about your behaviour and whether you are HIV-positive.
  • Follow safer sex practices, such as using condoms.
  • Do not donate blood, plasma, semen, body organs, or body tissues.
  • Track 2-1STI control to prevent HIV transmission
  • Track 2-2Behavioural interventions to prevent HIV transmission
  • Track 2-3Male and female condoms and other physical barriers
  • Track 2-4Using HIV Medication to Reduce Risk
  • Track 2-5Reducing Sexual Risk
  • Track 2-6Reducing Risk from Alcohol & Drug Use
  • Track 2-7Reducing Mother-to-Child Risk
  • Track 2-8Potential Future Options
  • Track 2-9Adherence to HIV prevention strategies

Sexually Transmitted Diseases (STDs) are infections that are passed from one person to another through sexual contact. The causes of STDs are bacteria, parasites, yeast, and viruses. There are more than 20 types of STDs. Most STDs affect both men and women, but in many cases the health problems they cause can be more severe for women. If a pregnant woman has an STD, it can cause serious health problems for the baby.

Antibiotics can treat STDs caused by bacteria, yeast, or parasites. There is no cure for STDs caused by a virus, but medicines can often help with the symptoms and keep the disease under control. Correct usage of latex condoms greatly reduces, but does not completely eliminate, the risk of catching or spreading STDs.

  • Track 3-1Chlamydia
  • Track 3-2Trichomoniasis (Trich)
  • Track 3-3Syphilis, and gonorrhea
  • Track 3-4Pelvic Inflammatory Disease (PID)
  • Track 3-5Molluscum Contagiosum
  • Track 3-6Trichomoniasis (parasitic infection)
  • Track 3-7Human Papillomavirus (HPV)
  • Track 3-8HIV/AIDS
  • Track 3-9Hepatitis B
  • Track 3-10Crabs (Pubic Lice)
  • Track 3-11Chancroid
  • Track 3-12Yeast infections

Hepatitis means inflammation of the liver. This condition is most often caused by a virus. The most common causes of viral hepatitis are hepatitis A virus (HAV), hepatitis B virus (HBV), and hepatitis C virus (HCV). HBV and HCV are common among people who are at risk for, or living with, HIV. You can get some forms of viral hepatitis the same way you get HIV—through unprotected sexual contact and injection drug use. HAV, which causes a short-term but occasionally severe illness, is usually spread when the virus is ingested from contact with food, drinks, or objects (including injection drug equipment), contaminated by feces (or stool) of an infected person.

  • Track 4-1Viral Hepatitis Transmission
  • Track 4-2HAV
  • Track 4-3HBV
  • Track 4-4HCV

Human Immunodeficiency Virus (HIV) infection was identified the number of children infected with HIV has risen dramatically in developing countries, the result of an increased number of HIV-infected women of childbearing age in these areas. HIV is a retrovirus and can be transmitted vertically, sexually, or via contaminated blood products or IV drug abuse. Vertical HIV infection occurs before birth, during delivery, or after birth. Urgent Need to Develop and Deliver Antiretroviral Treatment Formulations for Infants and Children with HIV/AIDS.

  • Track 5-1Paediatric HIV Roundtable with Industry Report
  • Track 5-2Optimizing HIV treatment options and identifying priority products for children
  • Track 5-3Developing priority paediatric products

Retroviruses are pleiotropically found in animals. Well-described examples include avian, murine and primate retroviruses. Two human retroviruses are especially important pathogens. These are the HIV and the human T-cell leukemia virus, HTLV. HIV causes AIDS while HTLV-I is the etiological agent for adult T-cell leukemia. There is a large amount of basic research being conducted on HIV and HTLV-I spanning gene expression, virus structure-assembly, integration, replication, and pathogenesis. Retro virology intends to cover these areas of human and animal retrovirus research.

  • Track 6-1Diagnosis of HIV infection in adults and children
  • Track 6-2Resistance and treatment failure
  • Track 6-3HIV-TB co-infection

·  Risk factors for acquisition, infectivity, progression and transmission of HIV

·  Epidemiology of opportunistic infections and co-infections

·   Molecular epidemiology

·  Diagnosis of HIV infection (detection of acute and recent HIV infection,including self testing)

·  Population-based surveys with HIV testing and viral load in epidemiology studies.


  • Track 7-1Risk factors for acquisition, infectivity, progression and transmission of HIV
  • Track 7-2Epidemiology of opportunistic infections and co-infections
  • Track 7-3Molecular epidemiology
  • Track 7-4Diagnosis of HIV infection (detection of acute and recent HIV infection, including self-testing)
  • Track 7-5Population-based surveys with HIV testing and viral load in epidemiology studies

The Immune system is composed of cells, organs, and proteins that work together to protect the body from viruses, bacteria, and other invaders. The immune response is the way in which your body recognizes and defends itself against bacteria, viruses, and other substances that are foreign and harmful. It is the job of the immune system to protect our bodies from harmful invaders by recognizing and responding to antigens. Typically proteins, antigens reside of the surface of cells, viruses, fungi, or bacteria, but antigens also may be non-living substances including toxins, chemicals, drugs, and foreign particles like splinters. The immune system remembers, recognizes, and destroys antigen-containing substances.

  • Track 8-1Innate immunity
  • Track 8-2Humoural immunity
  • Track 8-3Cellular immunity
  • Track 8-4Mucosal immunity
  • Track 8-5Virus escape from adaptive immunity

Co-infections or super-infections with a non-hepatitis virus are also possible, and for HIV population, it is quite common due to the similarities of the infection route. (About 40% of patients with HIV are co-infected with HCV.) For these conditions, the clinical symptoms and disease courses are usually more complex and serious than a single viral infection case.

Although super or co-infections can make the disease more severe and its progression faster, there is also the possibility that one of the agents, such as HCV, could help promote the clearings of the other virus, such as HBV, from the body. HCV could also take over the position of HBV and become the major virus to cause persistent chronic infection.


  • Track 9-1HIV-1 super-infection/inter/intra subtype co-infection
  • Track 9-2HIV-2
  • Track 9-3Viral hepatitis
  • Track 9-4Mycobacteria and tuberculosis
  • Track 9-5Other pathogens

Diagnosis of HIV infection can be carried out by detecting any of the following test Antibodies to HIV, P24 HIV antigen and HIV nucleic acid (RNA/DNA). The most commonly used method for the diagnosis of HIV infection is detection of anti-HIV antibodies in serum/plasma. It is economical, rapid and can be performed easily in most laboratories. HIV antibody assays are now commercially available in various formats. It is necessary to differentiate between HIV-1 and HIV-2 infections as the treatment varies for the two types. HIV-2 is intrinsically resistant to NNRTI drugs.

  • Track 10-1Novel assays of immune responses
  • Track 10-2Novel approaches to assess viral load and ARV resistance/tropism
  • Track 10-3Optimizing selection and procurement of existing paediatric products

Adults with immunodeficiencies are much more likely to suffer from molluscum contagiosum. Approximately 90% of patients who are HIV-positive have skin lesions of some sort, including molluscum contagiosum. In one study, 18% of patients who were HIV positive were found to have molluscum contagiosum (Rane et al., 2014).  Immunogenetics helps in understanding the pathogenesis of several autoimmune and infectious diseases and bacterial infections under clinical studies of STDs.

Mother-to-child transmission of HIV is the spread of HIV from an HIV-infected woman to her child during pregnancy, childbirth (also called labor and delivery), or breastfeeding. Mother-to-child transmission of HIV is also called perinatal transmission of HIV. Mother-to-child transmission is the most common way that children become infected with HIV. The HIV medicine reduces the risk of infection from any HIV that may have entered a baby’s body during childbirth.

  • Track 12-1Preventing new HIV infections among women of childbearing age
  • Track 12-2Preventing unintended pregnancies among women living with HIV